TipRanks
Go Ultimate55% OFF

Crispr Therapeutics AG (CRSP) Balance Sheet

Crispr Therapeutics AG Balance Sheet

Crispr Therapeutics AG's total assets for Q2 2026 were $2.65B, a decrease of 2.75% from the previous quarter. CRSP total liabilities were $904.22M for the fiscal quarter, a 0.77% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 2.27B$ 2.24B$ 2.23B$ 2.24B$ 2.75B
$ 343.43M$ 309.95M$ 346.77M$ 367.58M$ 352.42M
$ 1.92B$ 1.93B$ 1.88B$ 1.88B$ 2.40B

Currency in USD

Crispr Therapeutics AG Debt to Assets

01B2B3B0 %12 %24 %36 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets